Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China
· Delayed Price · Currency is CNY 20.43
+0.53 (2.66%)
Mar 10, 2026, 11:29 AM CST
Shanghai ZJ Bio-Tech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 2,783 | 2,769 | 3,148 | 2,936 | Upgrade
|
| Cash & Short-Term Investments | 2,815 | 2,783 | 2,769 | 3,148 | 2,936 | Upgrade
|
| Cash Growth | 1.12% | 0.50% | -12.02% | 7.21% | 143.70% | Upgrade
|
| Accounts Receivable | - | 55.27 | 102.1 | 227.63 | 218.39 | Upgrade
|
| Other Receivables | - | 22.78 | 25.05 | 9.45 | 75.76 | Upgrade
|
| Receivables | - | 78.05 | 127.15 | 237.08 | 294.15 | Upgrade
|
| Inventory | - | 57.37 | 253.6 | 504.03 | 299.47 | Upgrade
|
| Other Current Assets | - | 16.8 | 15.79 | 21.01 | 23.3 | Upgrade
|
| Total Current Assets | - | 2,936 | 3,166 | 3,910 | 3,553 | Upgrade
|
| Property, Plant & Equipment | - | 680.95 | 743.91 | 661.63 | 562.36 | Upgrade
|
| Long-Term Investments | - | 95.46 | 101.05 | 113.46 | 74.97 | Upgrade
|
| Goodwill | - | 5.4 | 5.4 | 5.4 | 5.4 | Upgrade
|
| Other Intangible Assets | - | 7.8 | 6.06 | 6.84 | 6.57 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 60.8 | 37.16 | 9.46 | 7.44 | Upgrade
|
| Long-Term Deferred Charges | - | 3.82 | 2.86 | 3.66 | - | Upgrade
|
| Other Long-Term Assets | - | 0.11 | 11.71 | 33.55 | 45.1 | Upgrade
|
| Total Assets | - | 3,790 | 4,074 | 4,744 | 4,255 | Upgrade
|
| Accounts Payable | - | 62.46 | 120.58 | 317.67 | 236.95 | Upgrade
|
| Accrued Expenses | - | 59.96 | 74.03 | 99.78 | 75.92 | Upgrade
|
| Current Portion of Leases | - | 1.73 | 2.81 | 2.94 | - | Upgrade
|
| Current Income Taxes Payable | - | 0.09 | 0.01 | 26.82 | 32.28 | Upgrade
|
| Current Unearned Revenue | - | 15.28 | 24.02 | 59.32 | 55.29 | Upgrade
|
| Other Current Liabilities | - | 6.46 | 15.12 | 17.33 | 8.56 | Upgrade
|
| Total Current Liabilities | - | 145.99 | 236.56 | 523.86 | 409 | Upgrade
|
| Long-Term Leases | - | 3.19 | 4.64 | 5.69 | - | Upgrade
|
| Long-Term Unearned Revenue | - | 3.88 | 7.59 | 11.71 | 13.74 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.45 | 2.17 | 4.54 | Upgrade
|
| Total Liabilities | - | 153.06 | 249.25 | 543.44 | 427.27 | Upgrade
|
| Common Stock | - | 192.16 | 194.7 | 194.7 | 194.7 | Upgrade
|
| Additional Paid-In Capital | - | 2,051 | 2,150 | 2,150 | 2,150 | Upgrade
|
| Retained Earnings | - | 1,438 | 1,587 | 1,953 | 1,458 | Upgrade
|
| Treasury Stock | - | -35.33 | -102.03 | -102.03 | - | Upgrade
|
| Comprehensive Income & Other | - | -8.88 | -4.51 | 4.73 | 24.35 | Upgrade
|
| Total Common Equity | 3,394 | 3,637 | 3,825 | 4,200 | 3,827 | Upgrade
|
| Shareholders' Equity | 3,394 | 3,637 | 3,825 | 4,200 | 3,827 | Upgrade
|
| Total Liabilities & Equity | - | 3,790 | 4,074 | 4,744 | 4,255 | Upgrade
|
| Total Debt | 200.51 | 4.93 | 7.45 | 8.63 | - | Upgrade
|
| Net Cash (Debt) | 2,614 | 2,778 | 2,762 | 3,139 | 2,936 | Upgrade
|
| Net Cash Growth | -5.92% | 0.60% | -12.01% | 6.92% | 143.70% | Upgrade
|
| Net Cash Per Share | 14.48 | 14.60 | 14.33 | 16.23 | 15.40 | Upgrade
|
| Filing Date Shares Outstanding | 171.35 | 189.84 | 192.16 | 192.16 | 194.7 | Upgrade
|
| Total Common Shares Outstanding | 177.52 | 189.84 | 192.16 | 192.16 | 194.7 | Upgrade
|
| Working Capital | - | 2,790 | 2,929 | 3,386 | 3,144 | Upgrade
|
| Book Value Per Share | 19.12 | 19.16 | 19.91 | 21.86 | 19.66 | Upgrade
|
| Tangible Book Value | 3,382 | 3,624 | 3,813 | 4,188 | 3,815 | Upgrade
|
| Tangible Book Value Per Share | 19.05 | 19.09 | 19.85 | 21.80 | 19.60 | Upgrade
|
| Buildings | - | 770.99 | 757.66 | 639.77 | 547.36 | Upgrade
|
| Machinery | - | 156.51 | 208.32 | 194.57 | 145.72 | Upgrade
|
| Construction In Progress | - | 0.34 | 2.12 | 1.18 | 0.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.